tiprankstipranks
Eli Lilly to acquire Sigilon Therapeutics for $14.92 per share in cash
PremiumThe FlyEli Lilly to acquire Sigilon Therapeutics for $14.92 per share in cash
2y ago
Sigilon Therapeutics reports Q4 EPS (21c), consensus (38c)
Premium
The Fly
Sigilon Therapeutics reports Q4 EPS (21c), consensus (38c)
2y ago
Sigilon Therapeutics initiated with a Buy at Canaccord
Premium
The Fly
Sigilon Therapeutics initiated with a Buy at Canaccord
2y ago
Sigilon’s SIG-007 Granted Orphan Drug Designation By FDA; Shares Pop 6%
PremiumMarket NewsSigilon’s SIG-007 Granted Orphan Drug Designation By FDA; Shares Pop 6%
4y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100